Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Update

14 Jul 2010 07:00

RNS Number : 2818P
Craneware plc
14 July 2010
 



Craneware plc

("Craneware" or the "Company")

 

Trading Update

 

14 July 2010 - Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, is pleased to give an update on trading for the year ended 30 June 2010.

 

Record Sales Year

 

Craneware continued to grow strongly during the year and expects to report results for the year ended 30 June 2010 in line with management expectations. The total value of contracts signed during the year will be the highest in the Company's history, increasing by over 25% against the prior year (2009 $43.2m). This growth is driven by the Company's increased product range and strengthening of its partner relationships, supported by favourable conditions in the US healthcare market. The majority of this revenue will, however, be recognised in future periods in accordance with the Company's annuity revenue model, adding to its already high visibility of future revenues.

 

Craneware will be announcing final results on Monday 6th September 2010.

 

Keith Neilson, CEO of Craneware commented, "This has been another strong year for Craneware, in which we have once again delivered high levels of sales growth. The ongoing healthcare reforms in the US have increased the need for our financial performance and risk mitigation solutions and we have continued to successfully execute on our strategy. These factors have resulted in another record year in terms of the total value of contracts signed during the period, increasing our high levels of visibility for future years and giving us a great platform on which to continue to grow. We therefore continue to be very confident regarding the future for Craneware and look forward to giving a full update at the time of our final results in September."

 

 

For further information, please contact:

 

Craneware plc

KBC Peel Hunt

Threadneedle Communications

+44 (0)1506 407 666

+44 (0)20 7418 8900

+44 (0) 20 7653 9850

Keith Neilson, CEO

Jonathan Marren

Caroline Evans-Jones

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Dan Webster

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Livingston, Scotland with offices in Atlanta, Florida, Arizona and Kansas, employing over 130 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGMNFFRGGZM
Date   Source Headline
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC
11th Jun 20252:40 pmGNWForm 8.3 - Craneware Plc
11th Jun 202512:02 pmGNWForm 8.3 - [CRANEWARE PLC - 10 06 2025] - (CGWL)
11th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.